SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-034164
Filing Date
2024-03-14
Accepted
2024-03-14 06:10:14
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm248020d2_8k.htm DEFA14A 120134
2 EXHIBIT 2.1 tm248020d2_ex2-1.htm EX-2.1 825494
3 EXHIBIT 3.1 tm248020d2_ex3-1.htm EX-3.1 88501
4 EXHIBIT 4.1 tm248020d2_ex4-1.htm EX-4.1 56632
5 EXHIBIT 10.1 tm248020d2_ex10-1.htm EX-10.1 345794
6 EXHIBIT 10.2 tm248020d2_ex10-2.htm EX-10.2 16581
7 EXHIBIT 10.3 tm248020d2_ex10-3.htm EX-10.3 99476
8 EXHIBIT 10.4 tm248020d2_ex10-4.htm EX-10.4 12476
9 EXHIBIT 10.5 tm248020d2_ex10-5.htm EX-10.5 17919
10 EXHIBIT 10.6 tm248020d2_ex10-6.htm EX-10.6 38736
11 EXHIBIT 10.7 tm248020d2_ex10-7.htm EX-10.7 8514
12 EXHIBIT 99.1 tm248020d2_ex99-1.htm EX-99.1 23363
13 GRAPHIC tm248020d2_ex10-7img001.jpg GRAPHIC 4996
  Complete submission text file 0001104659-24-034164.txt   1661905
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37853 | Film No.: 24747829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)